Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bedaquiline and Rifampicin for Leprosy Post-Exposure Prophylaxis (Phase 2)
NCT05406479Phase 2Completed
- Sponsor
- Institute of Tropical Medicine Antwerp
- Start
- Jul 2022
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bedaquiline in leprosy (HD), sponsored by Institute of Tropical Medicine Antwerp. Started Jul 2022; status: completed.
02
Drugs
bedaquiline
03
Conditions
leprosy (HD)
Beyond the preview
Go deeper on NCT05406479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05406479.